Open access
Effectiveness and Safety of Fixed‐Dose Combination Metformin and Empagliflozin in Type 2 Diabetes: A Prospective, Multicenter, Real‐World Study From China
Wei-Jian Ke
Ying-Hong Kong
Song-Bo Fu
Li-Yun Wang
Ying Pan
Shao Zhong
Yan-Hua Jiang
Hui Chen
Xue-Hua Jiao
Fu-Xing Sha
Li-Wu Xu
Wei Shao
F. Lan
Xiao-Li Chen
Bo Yan
Guang-Ju Zhou
Ping Shi
Fen Li
Hui-Ke He
Hong Li
Guang-Wu Zhang
Hongquan Duan
Fang Wang
Wei-Kun Gong
Yue-Wu Bai
Bin Wang
X. Mou
Li-Ying He
Wu Ma
Jun-Hua Song
Juan Zheng
Xiao-Su Bai
Xiao-Si Li
Xin Yan
Yan-Qiu Wang
Zhen-Hua Wang
Juan Yuan
Wei Lu
Yu-Zi Liang
Yu-Fan Wang
Fen-Juan Xu
Xue-Feng Li
Xuan Lin
Hong-Bin Zhu
Ling-Ling Xu
Xiaojia Lou
Ling-Xiao Wang
Li-Juan Cui
Li-Jun Wang
Hua Qian
Yuwen Shi
Yan-Bing Li
Medicine
Abstract
This study assessed the real‐world effectiveness and safety of a fixed‐dose combination (FDC) of metformin and empagliflozin in Chinese patients with type 2 diabetes mellitus (T2DM).